Latest news with #SchoolofClinicalMedicine
Boston Globe
23-05-2025
- Health
- Boston Globe
One type of mammogram proves better for women with dense breasts
The scans were given to women with dense breast tissue who had already undergone mammograms that had not turned up any abnormalities. Advertisement 'Contrast-enhanced mammography needs to become standard of care for women with dense breasts,' if they are at high risk of developing breast cancer, said Dr. Fiona J. Gilbert, a professor of radiology at the University of Cambridge's School of Clinical Medicine. She is lead author of the study, which was published Wednesday in The Lancet. Get Starting Point A guide through the most important stories of the morning, delivered Monday through Friday. Enter Email Sign Up Tumors typically show up as white spots on mammograms, but dense breast tissue also appears white, obscuring the tumors. 'When you have lots of white normal breast tissue, it's hard to see the white cancers,' Gilbert said. 'But when you do the contrast, the cancers take up the iodine, and all you're seeing is this cancer lighting up.' A large Dutch study published in 2019 showed that MRIs are more effective than standard mammography at finding tumors in dense breast tissue. The new study is the first randomized controlled clinical trial to compare MRIs, ultrasounds, and contrast-enhanced mammography in women with dense breast tissue. Advertisement JoAnn Pushkin, executive director of the educational group DenseBreast-info, said the study showed that contrast-enhanced mammograms could save lives. They not only found more tumors, but also detected them when they were small and had not yet spread to the lymph nodes. 'This means these cancers were found early enough that most were still contained within the breast,' Pushkin said. 'These were tragedies averted. If they had not been found, they would have grown undetected until they were horror stories.' But while contrast-enhanced mammography is available in some centers in the United States, its use for breast cancer screening has not been approved by the Food and Drug Administration. (It is more often used as a diagnostic tool after suspicious findings appear on a regular mammogram.) Partly that's because of concern over allergic reactions to the contrast agent, which are uncommon but can be severe, according to Dr. Wendie Berg, a professor of radiology at the University of Pittsburgh School of Medicine and chief scientific adviser to DenseBreast-info. Gilbert, the study's lead author, also cautioned that while extra imaging can lead to earlier detection in women with dense breasts, it may also increase overdiagnosis and overtreatment of a medical condition that may never become life-threatening if left alone. Yet most of the tumors detected with the contrast-enhanced scans actually were invasive and potentially life-threatening, Berg said. These cancers show up more readily when dye is used. Contrast-enhanced mammograms are more cost-effective than MRI scans, and they could be made more widely available at existing mammography centers with staff training and sometimes technology upgrades, Pushkin said. Advertisement The new study, carried out at 10 screening sites in the United Kingdom between Oct. 18, 2019, and March 30, 2024, was the kind of trial considered the gold standard in medicine. More than 9,000 women aged 50 to 70 who had dense breast tissue and normal mammograms were randomly assigned in roughly equal numbers to receive standard digital mammography, MRIs, ultrasounds, or contrast-enhanced mammography. About 6,305 completed the additional imaging tests. MRI scans turned up 17.4 cancers per 1,000 exams, while ultrasounds found only 4.2 cancers per 1,000 exams. Contrast-enhanced mammograms detected 19.2 cancers per 1,000 exams, but the difference between MRI and contrast-enhanced mammography was not statistically significant. Not all of the tumors were invasive. MRIs revealed 15 invasive cancers per 1,000 exams, ultrasounds found 4.2 invasive cancers per 1,000 exams, and contrast-enhanced mammography detected 15.7 invasive cancers per 1,000 exams. Most of the cancers were less than 2 centimeters in size, and had not spread to the lymph nodes. There were adverse events associated with the use of iodine dye. Twenty-four patients who underwent contrast-enhanced mammograms had reactions, and three experienced so-called extravasation, in which the dye leaks out of blood vessels into adjacent tissue. There were no adverse events associated with ultrasound, and there was one case of extravasation among the women who received MRIs, in which contrast dye is sometimes used. Among the trial participants whose cancer was discovered during a supplemental MRI was Louise Duffield, 60, who lives in Ely, near Cambridge. Duffield was invited to participate in the trial in 2023, after her regular mammogram screening showed that she had very dense breasts. When she came in for an extra MRI, the scan identified a small lump. Advertisement A biopsy determined that the tumor was Stage 0, or very early, and confined within the milk ducts. Duffield had surgery to remove the tumor six weeks later, by which time it had already grown larger than it had appeared on the scans, hospital officials said. Because of the location of the tumor, Duffield would have had difficulty identifying it with a self-exam. And since the tumor was not detected during her regular mammogram, she would not have had to come in for another scan for at least three years, based on UK guidelines. Duffield was treated with radiation and is now free of cancer. 'The tumor was deep in the breast, so if I hadn't been on the trial, it could have gone unnoticed for years,' Duffield said in a statement. 'Without this research, I could have had a very different experience.' This article originally appeared in
The Citizen
03-05-2025
- Health
- The Citizen
South Africa Olympic doctor bolsters UKZN's sports medicine division
INTERNATIONALLY recognised sports and exercise medicine physician, and former SA Olympic medical officer, Dr Phathokuhle Zondi, has officially started her tenure at the University of KwaZulu-Natal (UKZN). Zondi, who officially started her duties on May 1, was appointed to the School of Clinical Medicine where she has been tasked with strengthening UKZN's current focus areas in research, undergraduate and postgraduate teaching, and research supervision in the field of sports and exercise medicine. A formidable endurance athlete in her own right, Zondi has completed numerous ultra-marathons, multi-stage cycling races, triathlons, and even summited Mount Kilimanjaro. As she prepares for her journey in academia, Zondi encourages young people to take up the mantle of carving their own path in the field. She said, 'You don't have to have it all figured out from the start — but stay curious, stay committed, and stay kind. Your path may twist and turn, but everything you learn along the way will serve you. Don't let fear of failure hold you back. The world needs your voice, your ideas, and your courage — especially in spaces where people like you haven't always been seen or heard. Whatever you choose to pursue, carry it with intention.' Also Read: UKZN, Durban City FC sign groundbreaking partnership Zondi's career spans over many years and in honour of her service to her country she received a Ministerial Recognition Award in 2017. Zondi brings to UKZN a wealth of experience spanning elite sport, public health, and corporate governance. Her extensive leadership portfolio includes serving as Chief Medical Officer for Team South Africa at the 2014 Commonwealth Games, the 2016 Rio Paralympic Games, the 2017 World Games, and the 2020 Tokyo Olympic Games. From 2016 to 2024, she chaired the Medical Advisory Commission for the South African Sports Confederation and Olympic Committee (SASCOC), overseeing athlete care and clinical standards on the world stage. Her leadership roles include serving as secretary general of the College of Sports and Exercise Medicine South Africa, president of the South African Sports Medicine Association (2015–2017), associate editor of the British Journal of Sports Medicine, and senior medical educator for World Rugby. She is also on the international faculty of the IOC's Advanced Team Physician Course. For more from Berea Mail, follow us on Facebook, X and Instagram. You can also check out our videos on our YouTube channel or follow us on TikTok. Click to subscribe to our newsletter – here At Caxton, we employ humans to generate daily fresh news, not AI intervention. Happy reading!
